Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh (Q36876388)

16 August 2017

Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

16 August 2017

0 references

0 references

1 reference

1 reference

Shahinul Alam

1

1 reference

16 August 2017

Sheikh Mohammad Noor-E-Alam

2

1 reference

16 August 2017

Ziaur Rahman Chowdhury

3

1 reference

16 August 2017

Mahabubul Alam

4

1 reference

16 August 2017

Jahangir Kabir

5

1 reference

16 August 2017

1 May 2013

1 reference

World Journal of Hepatology

16 August 2017

1 reference

16 August 2017

5

1 reference

16 August 2017

5

1 reference

16 August 2017

281-287

1 reference

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Managing nonalcoholic fatty liver disease: recommendations for family physicians.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Pathogenesis of non-alcoholic steatohepatitis: human data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

GI epidemiology: nonalcoholic fatty liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Is serum gamma glutamyltransferase a marker of oxidative stress?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Non-alcoholic fatty liver disease: an overview

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

The prevalence and etiology of elevated aminotransferase levels in the United States

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Liver pathology and the metabolic syndrome X in severe obesity.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3664286

Nonalcoholic Steatohepatitis

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.4254%2FWJH.V5.I5.281

Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4254%2FWJH.V5.I5.281

Relationship of postprandial motilin, gastrin, and pancreatic polypeptide release to intestinal motility during vagal interruption

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23717739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23717739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nonalcoholic fatty liver disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23717739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4254/WJH.V5.I5.281

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

23717739

1 reference